Kawther Ali Zaher | Molecular Microbiology | Best Researcher Award

Prof. Dr. Kawther Ali Zaher | Molecular Microbiology | Best Researcher Award

Proffessor | King Abdulaziz University | Saudi Arabia

Prof. Dr. Kawther Ali Zaher, MD, VMD, MSc, PhD, is a distinguished Professor of Virology and Immunology at the King Fahd Medical Research Center and the Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia. She is a certified Biorisk Management Officer and Advisor by the International Federation of Biosafety Associations, recognized for her extensive expertise in molecular virology, immunology, and infectious diseases. Prof. Zaher holds advanced degrees in veterinary medicine, virology, and medicine from Cairo University and October 6 University, with a strong academic foundation in antiviral research and vaccine development. Her professional journey spans progressive roles from researcher to professor, during which she has successfully led national and international research projects, including those funded by the National Research Center, Egypt. Her pioneering work focuses on the diagnosis, control, and prevention of viral diseases affecting both human and animal health, contributing significantly to molecular virology advancements. Prof. Zaher has served as an editor for several international journals and is an active member of multiple professional associations, including the American Microbiology Association and the Egyptian Biosafety Association. Her leadership, dedication, and scholarly excellence have positioned her as an influential figure in biomedical research, inspiring innovation and collaboration in virology and immunology.

Profiles: Google Scholar | ORCID

Featured Publications

1. Zaher, K. S., Ahmed, W. M., & Zerizer, S. N. (2008). Observations on the biological effects of black cumin seed (Nigella sativa) and green tea (Camellia sinensis). Global Veterinaria, 2(4), 198–204.

2. Ahmed, W. M., & Zaher, K. S. (2008). Observations on lumpy skin disease in local Egyptian cows with emphasis on its impact on ovarian function. African Journal of Microbiology Research, 2(10), 252–257.

3. Zaher, K., Basingab, F., Alrahimi, J., Basahel, K., & Aldahlawi, A. (2023). Gender differences in response to COVID-19 infection and vaccination. Biomedicines, 11(6), 1677.

4. Zaher, K. S., & Ahmed, W. M. (2011). Investigation on Bovine Ephemeral Fever virus in Egyptian cows and buffaloes with emphasis on isolation and identification of a field strain. Global Veterinaria, 6(5), 447–452.

5. Zaher, K. S., & Ahmed, W. M. (2014). Bovine leukemia virus infection in dairy cows in Egypt. Academic Journal of Cancer Research, 7(2), 126–130.*

HIkmate Abriouel | Microbiology | Best Researcher Award 

Prof. HIkmate Abriouel | Microbiology | Best Researcher Award 

 Professor at University of Jaén ,Spain

Dr. Hikmate Abriouel is a distinguished Full Professor of Microbiology at the University of Jaén, Spain. With a PhD in Biological Sciences, she is a globally recognized researcher, featured in Stanford’s Top 2% Scientists list (2021–2024). Her academic career is marked by leadership in microbiological research and education. She leads the “Microbiology and Health” group, focusing on antimicrobial resistance and probiotics of vegetable origin. Currently serving as Vice-Rector of Official Education at the University of Jaén, she has contributed significantly to curriculum reform, including the implementation of the Medicine degree. Dr. Abriouel is deeply involved in international research collaborations, has mentored numerous PhD scholars, and is known for her strong commitment to science communication and outreach. Her scholarly work includes over 160 indexed articles and several editorial roles. She remains an influential figure in advancing microbiology through an inclusive, multidisciplinary, and globally connected research approach.

🔹Professional Profile 

🏆Strengths for the Award

  1. Outstanding Academic Record

    • PhD in Biological Sciences, extensive postdoctoral international training.

    • Over 160 indexed publications, with a Scopus h-index of 51 and 9400+ citations, reflecting sustained and influential scholarly output.

  2. Global Recognition

    • Consistently featured in Stanford’s Top 2% Scientists (2021–2024).

    • Recognized as a Highly Cited Researcher, indicating international impact.

  3. Research Leadership and Innovation

    • Leads the “Microbiology and Health” research group with a focus on AMR, probiotics, and One Health approaches.

    • 27 funded national and international research projects, many with cross-disciplinary and applied relevance.

    • Holds patents, showcasing translation of science into practical applications.

  4. Educational Contributions

    • Vice-Rector of Official Education at the University of Jaén.

    • Played a key role in launching the Medicine degree, driving academic reform.

    • Mentored over 12 PhD scholars, promoting the next generation of microbiologists.

  5. Knowledge Transfer & Industry Collaboration

    • Involved in 12 industry-partnered research contracts, bridging academia and the private sector.

    • Research has direct relevance to public health, food safety, agriculture, and biotechnology.

  6. Editorial and Community Engagement

    • Guest editor for top journals (e.g., Microorganisms, IJMS).

    • Active in science communication and promoting inclusive, multidisciplinary collaboration.

Education 

Dr. Hikmate Abriouel earned her PhD in Biological Sciences, laying a strong foundation for her career in microbiology. Her academic journey reflects a deep commitment to interdisciplinary and impactful scientific work. Her training involved in-depth exposure to microbiological sciences, biotechnology, and public health, particularly in food microbiology and antimicrobial resistance. Throughout her studies, Dr. Abriouel pursued advanced methodologies and scientific inquiry that would later define her contributions to the field. She enhanced her academic profile through research stays in Germany and France, gaining international perspectives on microbiological and public health challenges. These experiences enriched her approach to research, particularly in integrating laboratory-based microbiology with real-world applications. She continues to contribute to higher education as a professor and university leader, advocating for innovative learning models and curriculum reforms. Her educational background, bolstered by continuous learning and global academic exposure, plays a vital role in shaping her as a leader in microbiology and public health.

Professional Experience 

Dr. Hikmate Abriouel has over two decades of academic and research experience in microbiology. As a Full Professor at the University of Jaén, she leads the “Microbiology and Health” research group, specializing in antimicrobial resistance, probiotics, and One Health strategies. Her research spans 27 national and international projects, and she has collaborated with leading scientists across Europe. She also serves as Vice-Rector of Official Education, where she has played a transformative role in modernizing educational programs, notably initiating the university’s Medicine degree. Her experience includes consultancy through 12 industry-partnered research contracts under the university’s Knowledge Transfer Plan. In addition to her research and administrative duties, Dr. Abriouel has mentored more than 12 doctoral students and serves as guest editor for international scientific journals. Her work bridges academic research, industrial applications, and educational leadership, making her a prominent figure in shaping microbiological sciences at both institutional and international levels.

Awards and Honors

Dr. Hikmate Abriouel’s contributions have earned her numerous recognitions. She is featured among the world’s Highly Cited Researchers and listed in Stanford’s prestigious Top 2% Scientists (2021–2024). In acknowledgment of her scientific stature, she is a Permanent Member of the Royal Academy of Veterinary Sciences of Eastern Andalusia. Her scholarly excellence is reflected in her impressive citation record, with an h-index of 51 and over 9400 citations in Scopus, positioning her among the most influential microbiologists globally. She has also served as a guest editor for renowned journals such as International Journal of Molecular Sciences and Microorganisms, further validating her academic influence. She has received competitive research grants and recognition for industry-related knowledge transfer through her work with private-sector collaborations. Her leadership in university governance and public health research continues to attract accolades, positioning her as a key opinion leader in microbiology, public health, and higher education innovation.

Research Focus on Microbiology

Dr. Hikmate Abriouel’s research centers on critical areas of microbiology with global health implications. Her primary focus lies in antimicrobial resistance (AMR), where she explores resistance mechanisms at the phenotypic and genotypic levels, especially in the food chain. She integrates this research within the broader “One Health” framework, promoting a holistic approach to human, animal, and environmental health. She also pioneers studies in vegetable-origin probiotics, particularly from fermented olives, exploring their potential in promoting gut health. Another significant area of her work addresses the antimicrobial activity of substances against plant pathogens such as Xylella fastidiosa and Verticillium dahliae. She has published a patented surface disinfectant and has two more patents under process. Her contributions align with UN Sustainable Development Goals, notably Goal 2 (Zero Hunger) and Goal 12 (Responsible Consumption). Her research not only deepens scientific understanding but also contributes practical solutions for food safety, agriculture, and public health.

📚 Publications Top Notes

Co-cultures of lactic acid bacteria from Brazilian foods as inhibitors of Listeria monocytogenes and Escherichia coli O157:H7 biofilm formation

Authors: [Names not provided]
Journal: Heliyon (2025)
Summary:
This study investigates how combinations of lactic acid bacteria (LAB) isolated from traditional Brazilian foods can inhibit biofilm formation of dangerous pathogens like Listeria monocytogenes and E. coli O157:H7. The results suggest a natural, food-origin microbial solution for controlling biofilms in food safety.

Antimicrobial activity of environmental Bacillus spp. and Peribacillus spp. isolates linked to surfactin, fengycin, bacillibactin and lantibiotics

Authors: [Names not provided]
Journal: International Journal of Biological Macromolecules (2025)
Summary:
This paper examines the antimicrobial potential of environmental strains of Bacillus and Peribacillus, focusing on secondary metabolites like surfactin, fengycin, and lantibiotics. These compounds demonstrate promising bioactivity against pathogens, highlighting their value in biotechnology and natural antimicrobial development.

Transcriptomic analysis of sub-MIC Eugenol exposition on antibiotic resistance profile in Multidrug Resistant Enterococcus faecalis E9.8

Authors: [Names not provided]
Journal: Microbiological Research (2025)
Summary:
This study analyzes how exposing MDR Enterococcus faecalis to sub-inhibitory concentrations of eugenol affects its gene expression, especially related to antibiotic resistance. The transcriptomic data provide insights into the adaptive mechanisms of bacterial resistance and the potential of natural compounds like eugenol in controlling it.

A microalgae Picochlorum sp. AZL19 from Moroccan Mediterranean as a novel source of antioxidant compounds

Authors: [Names not provided]
Journal: Algal Research (2025)
Summary:
The research explores a newly isolated strain of Picochlorum microalgae from the Moroccan Mediterranean coast, emphasizing its production of antioxidant compounds. Findings support its potential in nutraceutical and cosmetic applications due to its bioactive properties.

Impact of disinfection methods used in the slaughterhouse environment on microbiome diversity throughout the meat production chain

Authors: [Names not provided]
Journal: Current Research in Microbial Sciences (2025)
Summary:
This article evaluates how various disinfection techniques in slaughterhouses influence the microbial diversity along the meat supply chain. The research underlines the need for microbiome-conscious disinfection strategies that balance hygiene with microbial ecosystem preservation.

Phenotypic and Genomic Insights Into Bacillus spp. and Peribacillus spp. of Spanish Olive Groves With Biotechnological Potential

Authors: [Names not provided]
Journal: Environmental Microbiology Reports (2024)
Summary:
The study combines phenotypic and genomic approaches to characterize Bacillus and Peribacillus species from olive grove soils in Spain. It highlights their potential in agricultural biotechnology, especially in biocontrol and plant growth promotion.

Exploring synergistic effects of essential oil compounds with antibiotics and biocides against multidrug-resistant foodborne pathogens

Authors: [Names not provided]
Journal: Applied Food Research (2024)
Summary:
This research investigates how combining essential oil components with traditional antibiotics and biocides can enhance antimicrobial efficacy against MDR foodborne pathogens. It supports the potential for integrated natural-synthetic antimicrobial strategies in food safety.

Corrigendum to “Virulence factors, antibiotic resistance, and bacteriocins in enterococci from artisan foods of animal origin”

Authors: [Names not provided]
Original Journal: Food Control (2009)
Summary:
This corrigendum addresses errors in the previously published article about enterococci strains from artisanal foods, focusing on virulence, resistance, and bacteriocin profiles. It ensures accuracy and clarity in the historical scientific record.

Dual effects of a bacteriocin-producing Lactiplantibacillus pentosus CF-6HA, isolated from fermented aloreña table olives, as potential probiotic and antimicrobial agent

Authors: [Names not provided]
Journal: Heliyon (2024)
Summary:
The article presents a strain of L. pentosus from olives with dual functionality—offering probiotic benefits and antimicrobial properties via bacteriocin production. It could serve both as a dietary supplement and a natural preservative.

Antimicrobial profile of the culturable olive sporobiota and its potential as a source of biocontrol agents for major phytopathogens in olive agriculture

Authors: [Names not provided]
Journal: Pest Management Science (2024)
Summary:
This study characterizes spore-forming microbes from olives and examines their antimicrobial activity against key phytopathogens. The results suggest that olive-associated sporobiota can be tapped for sustainable biocontrol in olive cultivation.

Conclusion 

Dr. Hikmate Abriouel exemplifies the blend of academic excellence, impactful research, and leadership in higher education. Her career spans advanced research in microbiology, dedication to combating global health threats like antimicrobial resistance, and a strong focus on food safety and sustainability. As a mentor and educator, she has shaped the careers of future scientists while playing a strategic role in enhancing medical education at the University of Jaén. Her interdisciplinary collaborations, both within Spain and internationally, reflect her ability to foster innovation through partnership. Recognition as a Highly Cited Researcher and her position in Stanford’s Top 2% Scientists underline the global impact of her work. Through her patented innovations, extensive publications, and academic governance, she continues to contribute meaningfully to both science and society. Dr. Abriouel’s career reflects a lifelong commitment to advancing microbiological science while supporting education, innovation, and inclusive scientific communication across local and global communities.

 

Leonardo Mayorga | Immunology and Microbiology | Best Researcher Award

Dr. Leonardo Mayorga | Immunology and Microbiology | Best Researcher Award 

Medical microbiologist at Universidad de Guadalajara Centro Universitario de Ciencias de la Salud: Guadalajara, Jalisco, Mexico

Leonardo Mayorga is a highly accomplished biologist specializing in medical microbiology and infectious diseases, with a particular focus on mycology and mycobacteriology. He holds a degree from the University of Guadalajara and advanced postgraduate training in his field. Leonardo combines clinical practice with academic excellence, serving as a professor in prestigious institutions such as the University of Milan and the Hospital General de Hermosillo. He is the founder of the dermatological mycology diploma at the Colegio Ibero Latinoamericano de Dermatología (CILAD), showcasing his commitment to advancing education in this niche. His leadership extends internationally as the Director of International Relations for the Worldwide Dermatology Collaboration Society, and nationally as the Secretary of the Mexican Association of Medical Mycology. Additionally, he contributes to scientific scholarship as a member of the editorial board for the Worldwide Dermatology Journal. Leonardo’s career reflects a blend of research, teaching, and professional service, marking him as a key figure in his specialized field of medical mycology.

Professional Profile 

ORCID Profile

Education

Leonardo Mayorga holds a degree in Biology from the University of Guadalajara, where he laid the foundation for his scientific career. He further specialized through postgraduate studies in Medical Microbiology and Infectious Diseases at the same university, deepening his expertise in the diagnosis and treatment of infectious pathogens. His academic training is complemented by focused clinical specialization in mycology and mycobacteriology, fields that require detailed knowledge of fungal and mycobacterial infections, respectively. This comprehensive education equips him to address complex infectious diseases from both a laboratory and clinical perspective. His continuous commitment to education is reflected in his roles as an educator and program founder, underlining a lifelong dedication to expanding knowledge in medical microbiology and infectious diseases.

Professional Experience

Leonardo Mayorga has built a distinguished professional career balancing clinical practice, teaching, and leadership roles. He operates a private diagnostic and research unit in Guadalajara, focusing on medical microbiology and infectious diseases. As an academic, he serves as a professor in several prestigious institutions, including the University of Milan and the Hospital General de Hermosillo, contributing to international and national training programs. Notably, he founded the dermatological mycology diploma program at the Colegio Ibero Latinoamericano de Dermatología (CILAD), demonstrating his commitment to education and specialization development. In addition, he holds leadership positions such as Director of International Relations for the Worldwide Dermatology Collaboration Society and Secretary of the Mexican Association of Medical Mycology, reflecting his influence within the scientific community.

Research Interest

Leonardo Mayorga’s primary research interests lie in the fields of medical mycology and mycobacteriology, focusing on the diagnosis, pathogenesis, and treatment of fungal and mycobacterial infections. He is particularly invested in advancing knowledge related to dermatological fungal diseases, a niche area critical for both clinical treatment and public health. His work aims to improve diagnostic methods and therapeutic strategies, bridging laboratory research with clinical applications. Additionally, he is involved in studying tropical infectious diseases, contributing to understanding their epidemiology and management. By combining clinical expertise with academic research, Leonardo’s efforts help enhance diagnostic accuracy, patient outcomes, and education in infectious diseases, fostering progress in both local and international healthcare environments.

Award and Honor

While specific awards and honors for Leonardo Mayorga are not detailed, his professional roles and appointments indicate significant recognition in his field. Serving as Secretary of the Mexican Association of Medical Mycology for the 2024-2026 term highlights his respected leadership among peers. His position on the editorial board of the Worldwide Dermatology Journal further reflects his standing in the scientific community as an expert and influencer. Being appointed Director of International Relations for the Worldwide Dermatology Collaboration Society underscores international trust in his ability to foster collaboration and advance the field globally. These roles collectively serve as professional honors that validate his expertise, dedication, and contributions to medical microbiology and dermatology.

Conclusion

Leonardo Mayorga exemplifies a dedicated scientist and educator with a specialized focus on medical mycology and infectious diseases. His solid academic background, combined with extensive clinical practice and international teaching experience, positions him as a leader in his field. He actively advances research, education, and professional collaboration through founding academic programs and holding key leadership roles. Though explicit awards are not noted, his appointments and editorial responsibilities reflect high peer recognition and influence. Leonardo’s career is marked by a commitment to improving infectious disease diagnosis and treatment, fostering international collaboration, and shaping the future generation of specialists. His blend of scientific rigor, educational innovation, and professional service makes him a prominent figure in medical microbiology and dermatological research worldwide.

Publications Top Notes

  • Title: Vasculonecrotic Reaction in an HIV/Leprosy Coinfected Subject Caused by Mycobacterium lepromatosis

    • Authors: Fernando Amador-Lara, Jorge Leonardo Mayorga-Garibaldi, Felipe Jesus Bustos-Rodríguez, Luz Gonzalez-Hernandez, Pedro Martínez-Ayala, Jaime Federico Andrade-Villanueva

    • Year: 2025

  • Title: Global Partnerships in Dermatology

    • Author: Leonardo Mayorga

    • Year: 2025

  • Title: Disseminated Sporotrichosis in A Patient with Iatrogenic Immunosuppression Due to Suspected Pyoderma Gangrenosum

    • Author: Leonardo Mayorga

    • Year: 2024

  • Title: Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico

    • Authors: Vera-Cabrera L, Ramos-Cavazos CJ, Nathan A. Youssef, Camron Pearce, Carmen Molina-Torres, Ramiro Avalos-Ramirez, Sebastien Gagneux, Ocampo-Candiani J, Gonzalez-Juarrero M, Mayorga-Rodriguez JA, et al.

    • Year: 2022

  • Title: Esporotricosis en animales domésticos

    • Author: Leonardo Mayorga

    • Year: 2021 (Book chapter)

  • Title: Tiña hiperqueratósica causada por Nannizzia gypsea: manifestación atípica en un paciente con VIH

    • Author: Leonardo Mayorga

    • Year: 2021

  • Title: Esporotricosis serie de 1,134 casos en una zona endémica de México

    • Author: Leonardo Mayorga

    • Year: 2019

  • Title: Inflammatory Tinea Manuum due to Trichophyton erinacei from an African Hedgehog

    • Author: Leonardo Mayorga

    • Year: 2018

Anish Maskey | Immunology and Microbiology | Best Researcher Award

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed